Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04544917 · ClinicalTrials.gov registry record · NA

SmartManage Stress Management for HIV+ Cancer Survivors

A NA study of Cancer and HIV, sponsored by University of Miami.

Completed
Registry status
NA
Development phase
32
Enrollment target
1
Study location

NCT04544917: Completed NA study of Cancer and HIV, sponsored by University of Miami.

NCT04544917 is a NA study of Cancer and HIV that has completed, run by University of Miami. The registered enrollment target is 32 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04544917, a NA study of Cancer and HIV, has completed, sponsored by University of Miami.

COMPLETED
Registry status
NA
Development phase
32 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to design and refine a web-based platform developed for managing symptom burden in men who have sex who are HIV+ cancer survivors.

Primary Outcome

Feasibility of the intervention will be reported as the proportion of eligible sexual minority men (SMM) who agree to participate versus decline

Conditions Studied

Interventions

  • BEHAVIORAL Educational Control
  • BEHAVIORAL SmartManage for HIV+ cancer survivors

Study Locations (1)

Florida

  • University of Miami - Miami

Trial Details

FieldValue
Enrollment Target 32 participants
Start Date 2021-02-15
Est. Completion 2024-09-03
Phase NA
University of Miami

721 total trials

What the finished NCT04544917 record still lists

NCT04544917 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 32 participants, a relatively small participant target, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (99% lower).

The record links to 3 conditions, with Cancer appearing as the primary indexed condition, and to 2 interventions - of which Educational Control is the first listed.

NCT04544917 reports a single indexed study location in Florida.

Frequently Asked Questions

What is clinical trial NCT04544917 about?

NCT04544917 is a clinical study titled "SmartManage Stress Management for HIV+ Cancer Survivors". The purpose of this study is to design and refine a web-based platform developed for managing symptom burden in men who have sex who are HIV+ cancer survivors.

What is the current status of trial NCT04544917?

This trial is currently completed. It is a NA study. The enrollment target is 32 participants. The study started on 2021-02-15. Estimated completion is 2024-09-03.

What conditions does trial NCT04544917 study?

This clinical trial studies the following conditions: Cancer, HIV, Stress.

What interventions are being tested in trial NCT04544917?

The interventions under investigation include: Educational Control (BEHAVIORAL), SmartManage for HIV+ cancer survivors (BEHAVIORAL).

Who is sponsoring clinical trial NCT04544917?

This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04544917 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04544917's enrollment target sits among peer trials

32 497th of 615 higher than 118 of 615 other Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02445781 · 32 participants · Early Phase 1

    Differing Levels of Hypoglycemia

  • NCT02792270 · 32 participants · NA

    Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT

  • NCT03068910 · 32 participants · Early Phase 1

    Hyperandrogenemia and Altered Day-night LH Pulse Patterns

  • NCT03208868 · 32 participants · NA

    Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04544917, the US trial registry maintained by the National Library of Medicine. NCT04544917 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.